Polarity Protein Scrib Facilitates Endothelial Inflammatory Signaling

Endothelial cells respond to inflammatory signals by altering adhesion molecule expression. Prior research has shown that integrin α5 and VCAM-1 are involved in this process. However, the role of polarity proteins in inflammatory signaling remains unclear. This gap motivated an investigation into how Scrib, a polarity protein, might influence endothelial inflammation. No prior work had resolved whether Scrib contributes to VCAM-1 induction. Established knowledge includes VCAM-1's role in leukocyte adhesion. This paper's contribution is identifying Scrib as a novel regulator of VCAM-1. The study builds on known inflammatory pathways but introduces a new player in endothelial signaling. It provides insights into mechanisms beyond integrin α5 and classic pathways.

The study aimed to determine if Scrib influences endothelial inflammatory signaling. The specific problem is understanding how Scrib affects VCAM-1 induction. The motivation comes from Scrib's role in integrin recycling and its presence in endothelial cells. Researchers wanted to test if Scrib is necessary for VCAM-1 upregulation. The hypothesis was that Scrib contributes to endothelial inflammatory responses. They focused on VCAM-1 as a key marker of inflammation. The study sought to clarify Scrib's function in this context. The goal was to assess whether Scrib is a proinflammatory regulator in endothelial cells.

The study used human umbilical vein endothelial cells and endothelial-specific Scrib knockout mice. Cytokine treatments were applied to induce inflammation. VCAM-1 expression was measured to assess inflammatory responses. Scrib was downregulated using small interfering RNAs. Leukocyte adhesion was tested in response to tumor necrosis factor-α. In vivo experiments used tamoxifen-induced deletion of Scrib. Co-immunoprecipitation and mass spectrometry identified interacting proteins. The study also assessed integrin α5 and classic inflammatory pathways.

Scrib downregulation reduced VCAM-1 induction in human endothelial cells. In mice, Scrib deletion impaired VCAM-1 response to lipopolysaccharide. Leukocyte adhesion to VCAM-1 was attenuated in Scrib-deficient cells. The effect was specific to Scrib and not other polarity proteins. GATA-like protein-1 was identified as a novel Scrib-interacting protein. Silencing GATA-like protein-1 reduced VCAM-1 induction similarly to Scrib loss. Scrib silencing reduced GATA-like protein-1 protein levels but not mRNA. The effect was independent of integrin α5 and classic signaling pathways.

The authors propose that Scrib is a novel proinflammatory regulator in endothelial cells. They suggest that Scrib maintains GATA-like protein-1 protein levels. The findings indicate that Scrib functions independently of integrin α5. The study shows that Scrib's role is specific and not shared by other polarity proteins. VCAM-1 induction is reduced when Scrib is absent. The effect is functionally relevant in both in vitro and in vivo models. The results support the idea that Scrib contributes to inflammatory signaling. The mechanism involves GATA-like protein-1 but not classic pathways.